The Russian pharmaceutical company “Nanolek” was founded in 2011. It specializes in the production of import-substituting medicines for the prevention and treatment of socially significant diseases.
In 2020, the company was recognized as a backbone enterprise of the Russian economy. In 2021, “Nanolek” was included in RBC’s rating — “50 Fastest Growing Companies in Russia”.
“Nanolek” has accumulated a unique experience in technology transfer:
more than 10 innovative drugs have been localized at the plant in the Kirov region in partnership with big pharma companies — world industry leaders.